Tavapadon (Juvmo) is a new once-daily pill for Parkinson’s motor symptoms. Here’s how it works, who it may help and what to ...

While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can present differently in everyone. Because of this, it's harder to identify ...

In the Phase 3 TEMPO program, AbbVie’s Juvmo elicited significant improvements in motor symptoms and prolonged periods with ...

AbbVie recently received U.S. FDA approval for JUVMO (tavapadon) tablets, the first and only selective D1/D5 receptor agonist ...

When it comes to Parkinson's disease, we inevitably focus on "movement," such as tremors, freezing of gait, and rigidity.But ...

Many people think of a tremor as the quintessential warning sign of Parkinson’s disease. But other symptoms — many of them not involving changes in movement — can appear much earlier than what’s known ...

A 39-year-old's heart paused for 15 seconds during a blood draw, and he needed chest compressions. He had fainted during a blood draw once before. A Man Came In for Swollen Feet and a Foot Wound, and ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for the treatment of ...

FDA gives go-ahead to D1/D5 dopamine agonist tavapadon ...